Cargando…
Keap1/Nrf2 Signaling: A New Player in Thyroid Pathophysiology and Thyroid Cancer
The Keap1/Nrf2 pathway is a key mediator of general redox and tissue-specific homeostasis. It also exerts a dual role in cancer, by preventing cell transformation of normal cells but promoting aggressiveness, and drug resistance of malignant ones. Although Nrf2 is well-studied in other tissues, its...
Autores principales: | Renaud, Cedric O., Ziros, Panos G., Chartoumpekis, Dionysios V., Bongiovanni, Massimo, Sykiotis, Gerasimos P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687762/ https://www.ncbi.nlm.nih.gov/pubmed/31428048 http://dx.doi.org/10.3389/fendo.2019.00510 |
Ejemplares similares
-
The Keap1/Nrf2 Signaling Pathway in the Thyroid—2020 Update
por: Thanas, Christina, et al.
Publicado: (2020) -
A Bibliometric Review of the Keap1/Nrf2 Pathway and its Related Antioxidant Compounds
por: Paunkov, Ana, et al.
Publicado: (2019) -
SAT-455 Mouse Thyroid Responds to Iodine Overload by Transcriptionally Enhancing the Keap1/Nrf2 Antioxidant Response and by Upregulating Nrf2-Dependent and Independent Inflammatory and Fibrosis Pathways
por: Chartoumpekis, Dionysios V, et al.
Publicado: (2020) -
Patent Review (2017–2020) of the Keap1/Nrf2 Pathway Using PatSeer Pro: Focus on Autoimmune Diseases
por: Chartoumpekis, Dionysios V., et al.
Publicado: (2020) -
Mice Hypomorphic for Keap1, a Negative Regulator of the Nrf2 Antioxidant Response, Show Age-Dependent Diffuse Goiter with Elevated Thyrotropin Levels
por: Ziros, Panos G., et al.
Publicado: (2021)